GenxoneS.A.Status: Entity active
Research and experimental development on biotechnology
KRS: 0000743838 NIP: 7811918132 REGON: 36294349700000
Overview
Registry date
2018-08-08
Share capital
$892,712.05
Activity description
Genxone is a laboratory specializing in next generation sequencing (NGS) and molecular diagnostics, utilizing nanopore sequencing technology developed by Oxford Nanopore Technologies. It offers a range of sequencing services, including metagenomic sequencing, 16s and/or ITS gene sequencing, and whole genome sequencing. Additionally, Genxone provides custom-designed analysis and bioinformatics services.
Registered address
Ul. Kobaltowa 6, 62-002 Złotniki, Poland
Website
genxone.euWebsite active
Email
[email protected]Email address current
Industry
| Name | Code |
|---|---|
Research and experimental development on biotechnologyPrimary | 72.11.Z |
Manufacture of medical and dental instruments and supplies | 32.50.Z |
Wholesale of pharmaceutical goods | 46.46.Z |
Wholesale of computers, peripheral equipment and software | 46.51.Z |
Retail sale of medical and orthopaedic goods in specialised stores | 47.74.Z |
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| UrtesteS.A. | $759,709.35 | urteste.com | |
| GenomtecS.A. | $654,973.69 | genomtec.com | |
| Syventosp. z o.o. | $599,926.58 | syvento.com | |
| Polbiotech Laboratoriumsp. z o.o. | $523,847.41 | polbiotech.pl | |
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | |
| Proper Medical Writingsp. z o.o. | $464,661.73 | propermedicalwriting.com | |
| Fundacja W Harmonii Z NaturąFoundation | $402,072.30 | fundacjanatura.pl | |
| Phage Consultantssp. z o.o. | $390,539.46 | phageconsultants.com | |
| BiottsS.A. | $372,115.51 | biotts.com | |
| Medicofarma BiotechS.A. | $330,994.74 | medicofarmabiotech.pl |
Last updated: 2025-12-14